First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy

BACKGROUND: Helicobacter pylori (H. pylori) treatment remains a challenge for physicians. Although highly effective, the standard sequential therapy fails in a certain number of patients. Moreover, the cure rate following a levofloxacin-amoxicillin second-line triple therapy seems to be decreasing....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zullo, Angelo, Ridola, Lorenzo, Efrati, Cesare, Giorgio, Floriana, Nicolini, Giorgia, Cannaviello, Claudio, Alvaro, Domenico, Hassan, Cesare, Gatta, Luigi, Francesco, Vincenzo De
Format: Artigo
Idioma:Inglês
Publicat: Hellenic Society of Gastroenterology 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4188933/
https://ncbi.nlm.nih.gov/pubmed/25330819
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars